Illumina Delivers Personal Genome Sequencing Results to First Consumer: Amadeus Capital's Hauser
September 02, 2009
Illumina Delivers Personal Genome Sequencing Results to First Consumer: Amadeus Capital's Hauser
As the first consumer to receive his genome through Illumina's individual genome-sequencing service, Hermann Hauser received his results at an Aug. 20 ceremony at Illumina's San Diego headquarters.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- FDA Warns DTC Genomics Firms that Genetic Tests are Not LDTs, May Need Clearance or Approval
June 16, 2010 / Pharmacogenomics Reporter - Illumina's New DTC Sequencing Service Addresses Ethical Quandary by Requiring Prescription
June 10, 2009 / Pharmacogenomics Reporter - CDC Advises Docs to Inform Patients of Limitations of DTC Gene Scans
August 11, 2010 / Pharmacogenomics Reporter - In Wake of 'Flawed' GAO Report, Consumer Genomics Firms Call for Regulatory Plan for DTC Industry
July 28, 2010 / Pharmacogenomics Reporter - DTC Genomics Gets Time Before FDA as Agency Considers Regulatory Strategy
July 21, 2010 / Pharmacogenomics Reporter